mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
UNC1215 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |